TAK1 is an essential kinase for STING trafficking

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Stimulator of interferon genes (STING) translocation from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC) is essential for its activation.
• The precise mechanisms regulating STING's ER exit remain largely unknown.

Purpose of the Study:

• To elucidate the regulatory mechanism of STING exit from the ER.
• To identify key molecular players involved in STING trafficking and activation.

Main Methods:

• Investigated the interaction between STING and TAK1 (transforming growth factor beta-activated kinase 1).
• Utilized biochemical assays to determine STING phosphorylation sites and their functional consequences.
• Employed a mouse allograft tumor model to assess the in vivo impact of TAK1 activation on STING-mediated immunity.

Main Results:

• STING activates TAK1 in a TAB1-dependent manner prior to its own trafficking.
• Activated TAK1 phosphorylates STING at serine 355, promoting its interaction with STEEP (STING ER exit protein).
• This phosphorylation facilitates STING oligomerization, ERGIC translocation, and subsequent activation, enhancing antitumor immunity.

Conclusions:

• TAK1 acts as a critical checkpoint for STING activation by regulating its ER exit and trafficking.
• TAK1-mediated STING phosphorylation is a key mechanism for controlling STING-dependent immune responses.
• Targeting TAK1 offers a potential strategy for enhancing STING-based cancer immunotherapy.